Vaxcyte's GAAP loss for 6M 2021 was $44.899 million, down 5.4% from $47.462 million in the previous year.
Vaxcyte's GAAP loss for 6M 2021 was $44.899 million, down 5.4% from $47.462 million in the previous year.
Financial results
Vaxcyte's GAAP loss for 6M 2021 was $44.899 million, down 5.4% from $47.462 million in the previous year. Source: 
investors.vaxcyte.com
investors.vaxcyte.com News feed
English (US) 